Insights
Filter by Category
Articles
Harnessing the untapped potential of medicines access
Medicines access is a service that offers patients who have an unmet clinical need the ability to obtain treatment, which can often boost their quality of life, be life-extending or even lifesaving. However, there are multiple barriers to overcome when it comes to supply. Access services work through these hurdles to ensure minimal delays to the patient, while exploring the untapped opportunities available to pharmaceutical companies.
How to ensure transparency in your clinical trial
Good communication is vital for running a successful clinical trial, and ensuring the clinical secondary packaging is both efficient and traceable is essential. Pharmaceutical Technology sat down with experts from BAP Pharma to discuss how transparency is key when considering your clinical trial supply strategy.
How to manage temperature-controlled shipments in unpredictable climate zones
Due to the increasing impact of climate change, drug packaging and shipping sectors have had to adapt by necessity. Clinical supplies expert Dr Simon Magness discusses how BAP Pharma adheres to the stringent requirements for shipping temperature-sensitive drugs around the globe amid increasingly challenging conditions.
Overcoming regulatory issues with investigational medicinal product labelling
For clinical trials operating across different counties, challenges with regulatory requirements must be overcome to avoid delays, while text translations need to be precise to ensure consistency globally while maintaining country-specific demands.
Medicines access: Unlocking the immense potential in cell and gene therapy
Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant or unable to invest in cell and gene therapy. Here, we discuss the key challenges to access and how the potential of these innovative treatments can be unlocked.
Please complete the form below to access your copy of this .